PharVision Advisers’s Bumble BMBL Stock Holding History

PharVision Advisers’s Portfolio BMBL Stock Details BMBL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,880	Closed	-$53.1K	–	165
2025 Q4	$53.1K	Sell	14,880 -59,161	-80%	-$262K	0.03%	667
2025 Q3	$451K	Buy	+74,041	New	+$506K	0.25%	41

Other funds holding BMBL

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

AGFVA

Accel Growth Fund V Associates Palo Alto, California $81.7M AUM 29.05% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PharVision Advisers's BMBL Position: Q1 2026 in Review

PharVision Advisers sold out of Bumble (BMBL) in Q1 2026, closing a stake of 14,880 shares — an estimated $53.1K sold.

PharVision Advisers first reported a position in BMBL in Q3 2025 and held it in 2 quarters. The position peaked at $451K in Q3 2025. 213 funds tracked by Wall St. Rank hold BMBL as of Q1 2026.

PharVision Advisers reported no remaining Bumble position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 14,880 Bumble shares in Q1 2026, an estimated $53.1K.
PharVision Advisers first reported a position in Bumble in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Bumble position peaked at $451K in Q3 2025.
213 funds tracked by Wall St. Rank held Bumble as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.